Archive | ARTES Biotechnology GmbH

Page 3 of 5
Recombinant Protein Production and Purification: cell line and process development
Recombinant Protein Production and Purification: cell line and process development Learn More >
ARTES adds SplitCore technology to vaccine development portfolio
ARTES adds SplitCore technology to vaccine development portfolio Learn More >
Vaccine development – ARTES
Vaccine development – ARTES Learn More >
ARTES and Minapharm join forces to package biopharma solutions
ARTES and Minapharm join forces to package biopharma solutions Learn More >
Recombinant protein production – ARTES
Recombinant protein production – ARTES Learn More >
ARTES successfully completes EU-funded project PLURIVAX
ARTES successfully completes EU-funded project PLURIVAX Learn More >
ARTES presenting protein production and vaccine development opportunities at BIO-Europe 2018
ARTES presenting protein production and vaccine development opportunities at BIO-Europe 2018 Learn More >
Establishment of a yeast-based VLP platform for antigen presentation
Establishment of a yeast-based VLP platform for antigen presentation Learn More >
ARTES brings new vaccine advances to veterinary ‘Dragons’ Den’
ARTES brings new vaccine advances to veterinary ‘Dragons’ Den’ Learn More >
ARTES seeking new collaborations at BioFIT 2017
ARTES seeking new collaborations at BioFIT 2017 Learn More >
ARTES receives French CIR Research Tax Credit Accreditation
ARTES receives French CIR Research Tax Credit Accreditation Learn More >
EU patent grant for ARTES Biotechnology METAVAX®
EU patent grant for ARTES Biotechnology METAVAX® Learn More >
Page 3 of 5